Geode Capital Management, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.33 - $1.39 $115,305 - $485,682	-349,412 Reduced 90.21%	37,934 $48,000
Q4 2022 Feb 13, 2023	SELL	$0.5 - $0.72 $12,527 - $18,039	-25,055 Reduced 6.08%	387,346 $205,000
Q2 2022 Aug 12, 2022	SELL	$0.86 - $2.06 $5,302 - $12,701	-6,166 Reduced 1.47%	412,401 $470,000
Q1 2022 May 13, 2022	BUY	$1.83 - $3.02 $115,396 - $190,435	63,058 Added 17.74%	418,567 $858,000
Q4 2021 Feb 11, 2022	BUY	$2.88 - $4.3 $16,522 - $24,669	5,737 Added 1.64%	355,509 $1.02 Million
Q3 2021 Nov 12, 2021	BUY	$3.72 - $5.35 $99,167 - $142,620	26,658 Added 8.25%	349,772 $1.48 Million
Q2 2021 Aug 13, 2021	BUY	$3.83 - $5.98 $322,451 - $503,462	84,191 Added 35.24%	323,114 $1.71 Million
Q1 2021 May 12, 2021	BUY	$3.33 - $8.76 $233,476 - $614,189	70,113 Added 41.53%	238,923 $1.11 Million
Q4 2020 Feb 12, 2021	BUY	$3.27 - $4.64 $12,756 - $18,100	3,901 Added 2.37%	168,810 $557,000
Q3 2020 Nov 13, 2020	SELL	$3.23 - $4.3 $7,965 - $10,603	-2,466 Reduced 1.47%	164,909 $545,000
Q2 2020 Aug 13, 2020	SELL	$3.31 - $6.54 $437,049 - $863,535	-132,039 Reduced 44.1%	167,375 $564,000
Q1 2020 May 14, 2020	BUY	$2.9 - $6.16 $57,753 - $122,676	19,915 Added 7.13%	299,414 $1.15 Million
Q4 2019 Feb 13, 2020	BUY	$5.61 - $8.57 $26,641 - $40,698	4,749 Added 1.73%	279,499 $1.69 Million
Q3 2019 Nov 12, 2019	BUY	$7.56 - $15.44 $125,805 - $256,937	16,641 Added 6.45%	274,750 $2.08 Million
Q2 2019 Aug 14, 2019	BUY	$5.4 - $15.5 $835,023 - $2.4 Million	154,634 Added 149.44%	258,109 $3.5 Million
Q1 2019 May 14, 2019	BUY	$3.6 - $6.22 $6,580 - $11,370	1,828 Added 1.8%	103,475 $560,000
Q4 2018 Feb 13, 2019	SELL	$2.89 - $7.91 $2,465 - $6,747	-853 Reduced 0.83%	101,647 $301,000
Q3 2018 Nov 13, 2018	BUY	$5.59 - $10.45 $149,325 - $279,150	26,713 Added 35.25%	102,500 $835,000
Q2 2018 Aug 14, 2018	SELL	$7.98 - $12.39 $203,609 - $316,130	-25,515 Reduced 25.19%	75,787 $738,000
Q1 2018 May 15, 2018	BUY	$8.49 - $13.46 $9,296 - $14,738	1,095 Added 1.09%	101,302 $880,000
Q4 2017 Feb 13, 2018	BUY	$8.69 - $14.59 $22,811 - $38,298	2,625 Added 2.69%	100,207 $1.25 Million
Q3 2017 Nov 14, 2017	BUY	$5.73 - $9.44 $8,234 - $13,565	1,437 Added 1.49%	97,582 $815,000
Q2 2017 Aug 14, 2017	BUY	N/A	96,145	96,145 $1.63 Million

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account